Related Experiment Videos
Keratoacanthoma following pneumococcal vaccination: a case report
The Journal of Dermatologic Surgery and Oncology
|May 1, 1983
Summary
A rare complication of pneumococcal vaccination occurred when a woman with chronic pulmonary disease developed a keratoacanthoma at the injection site. This case highlights a potential, though infrequent, adverse reaction to the polyvalent pneumococcal polysaccharide vaccine.
Area of Science:
- Immunology
- Dermatology
- Vaccinology
Background:
- Pneumococcal vaccination is crucial for individuals with chronic pulmonary disease to prevent serious infections.
- Polyvalent pneumococcal polysaccharide vaccine (PPSV23) is commonly administered to at-risk populations.
- Adverse events following vaccination are typically mild and localized.
Observation:
- A patient with chronic pulmonary disease received polyvalent pneumococcal polysaccharide vaccine.
- A keratoacanthoma, a benign skin tumor, developed at the vaccine injection site.
- This specific adverse event following pneumococcal vaccination is not widely documented.
Findings:
- The development of a keratoacanthoma at the injection site following pneumococcal vaccination is reported.
- This suggests a potential localized inflammatory or reactive process triggered by the vaccine in susceptible individuals.
- The precise mechanism linking pneumococcal vaccination to keratoacanthoma formation requires further investigation.
Implications:
- Healthcare providers should be aware of rare potential skin reactions post-vaccination.
- Further research may be warranted to understand the immunologic or cellular mechanisms involved.
- This case contributes to the pharmacovigilance data on pneumococcal vaccines.